Treace Medical Concepts Inc Stock News

PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ®  and Adductoplasty ®  Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. ...

Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2024 Earnings Call November 5, 2024 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations John Treace - Chief Executive Officer Mark Hair - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Danielle Antalffy - UBS Operator Good day and thank you for standing by. Welcome to the Treace Medical Concepts Thi...

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ:TMCI) on behalf of Treace stockholders. Our investigation concerns whether Treace has violated the federal securities laws and/or engaged in other unlawful busines...

PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the third quarter ended September 30, 2024.

PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ®  and Adductoplasty ®  Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. ...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Treace investments or w...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) investors concerning the Company's possible violations of federal securities laws. On May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approxima...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On May 7, 2024, Treace released its first quarter 2024 financi...